Finance

Beta
Lists
RNAZ:NASDAQ
Transcode Therapeutics Inc
$5.56
-4.71%
(-0.28) 1D
Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RNAZ...
Open
$5.76
High
$6.30
Low
$5.52
Mkt. cap
5.29M
Avg. vol.
91.81K
Volume
0.00
52-wk high
$20.99
52-wk low
$3.85
EPS
-$48.72
Beta
1.28
Shares outstanding
950.00K
No. of employees
12
Open
$5.76
High
$6.30
Low
$5.52
Mkt. cap
5.29M
Avg. vol.
91.81K
Volume
0.00
52-wk high
$20.99
52-wk low
$3.85
EPS
-$48.72
Beta
1.28
Shares outstanding
950.00K
No. of employees
12
News stories
From sources across the web
About Transcode Therapeutics Inc
CEO-
Employees12
Founded2016
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitetranscodetherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.57M
3.16M
5.48M
5.11M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.66M
1.40M
1.76M
2.22M
Operating expense
4.22M
4.56M
7.24M
7.33M
Total operating expenses
4.22M
4.56M
7.24M
7.33M
Operating income
-4.22M
-4.56M
-7.24M
-7.33M
Other non operating income
-8.03K
-256.99K
1.15M
14.49K
EBT including unusual items
-4.28M
-4.86M
-13.22M
-17.55M
EBT excluding unusual items
-4.28M
-4.86M
-6.01M
-7.24M
Income tax expense
-
-
226.07K
231.31K
Effective tax rate
-
-
-1.71%
-1.32%
Other operating expenses
-
-
-
-
Net income
-4.28M
-4.86M
-13.44M
-17.79M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
148.00
147.00
78.76K
91.89K
Interest expense
-
-5.96K
-542.00
-
Net interest expenses
148.00
-5.81K
78.22K
91.89K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.21M
-4.56M
-7.19M
-7.30M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer